Koala Chlamydia: A Wildlife Disease and Welfare Crisis

Chlamydia is the most significant infectious disease threat to wild koala populations, causing blindness, reproductive failure, and painful urinary tract disease in a large proportion of koalas across eastern Australia. It is a major welfare crisis that intersects with conservation concern.

Key Facts

Chlamydia pecorum infection affects koalas across much of their Australian range; in some populations, infection rates exceed 80-90% of individuals
Chlamydia causes: ocular disease (conjunctivitis progressing to blindness), urinary tract disease (wet bottom, cystitis), and reproductive failure (infertility in females) — all significantly impairing welfare and survival
Affected koalas are often found on the ground (unable to climb due to blindness or weakness), at increased risk of dog attacks, vehicle strikes, and starvation
Antibiotic treatment (typically doxycycline or chloramphenicol) is effective but requires capture of wild animals — carrying its own welfare costs — and cannot address the systemic population burden
A Chlamydia vaccine for koalas was developed by researchers at the University of the Sunshine Coast; Phase 3 trials demonstrated significant protection — it is now being deployed in some populations
Koala habitat loss through land clearing for agriculture and urban development is the primary driver of population decline; chlamydia compounds an already-stressed population
Queensland and New South Wales have listed koalas as Endangered under national environmental law, reflecting the combined pressure of disease, habitat loss, and vehicle strikes

Welfare Considerations

Chlamydia causes significant individual suffering in affected koalas: ocular disease that progresses to blindness is painful and functionally devastating for an arboreal species; urinary tract infection causes the characteristic "dirty tail" — wet, scalded, infected perineal skin that represents constant discomfort. Blind koalas cannot navigate their arboreal environment safely, cannot forage effectively, and are extremely vulnerable to predation and vehicle strikes. Wildlife hospitals around Australia treat hundreds of chlamydia-affected koalas annually — each treatment case represents genuine acute welfare intervention. The vaccine represents a transformative welfare advance: preventing infection eliminates the suffering rather than treating it after the fact. Deployment at population scale is the welfare priority.

What You Can Do

Support Australia Zoo Wildlife Hospital, RSPCA Queensland, and local wildlife hospitals that treat injured and ill koalas
Donate to koala vaccine research and deployment programmes through the University of the Sunshine Coast's Save Our Koalas programme
If you live in koala habitat, drive slowly at night (koalas are most active after dark), keep dogs secured, and plant koala food trees (eucalyptus species)
Support land clearing regulation that protects koala habitat corridors — habitat loss is the primary driver of population vulnerability to disease
Report sick or injured koalas to wildlife rescue organisations immediately — early treatment dramatically improves individual outcomes